You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mFOLFOX6

Showing 26 - 50 of 346
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer (mCRC) Trial in Nanjing (HLX04 100 mg in 4 ml Injection, Avastin 100 mg in 4 ml Injection)

Active, not recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • HLX04 100 mg in 4 ml Injection
  • Avastin 100 mg in 4 ml Injection
  • Nanjing, Jiangsu, China
    Nanjing Bayi Hospital Ethics Committee
May 6, 2022

Colorectal Carcinoma, Liver Metastases Trial in Shanghai (mFOLFOXIRI regimen, mFOLFOX regimen, Bevacizumab)

Recruiting
  • Colorectal Carcinoma
  • Liver Metastases
  • mFOLFOXIRI regimen
  • +2 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Sep 22, 2021

Colo-rectal Cancer, Capecitabine, Cetuximab Trial in Chengdu (mCapOX plus cetuximab, mFOLFOX6 plus cetuximab)

Recruiting
  • Colo-rectal Cancer
  • +2 more
  • mCapOX plus cetuximab
  • mFOLFOX6 plus cetuximab
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Sep 1, 2021

(NCT02394834) in Advanced/Recurrent Colorectal Cancer

Recruiting
  • Colorectal Cancer
  • mFOLFOX6 + panitumumab combination therapy
  • mFOLFOX6 + bevacizumab combination therapy
  • Tokyo, Japan
    Takeda selected site
Sep 28, 2021

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

Available
  • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
  • +3 more
  • Morristown, New Jersey
    AMG Hematology/Oncology
Sep 15, 2023

Neoadjuvant Treatment, Rectal Cancer, Cetuximab Trial in Shanghai (cetuximab+mFOLFOX6, short-course radiotherapy)

Recruiting
  • Neoadjuvant Treatment
  • +3 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Apr 15, 2022

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • mFOLFIRINOX adjuvant chemotherapy
  • mFOLFOX6/XELOX adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 12, 2023

Apatinib Trial in Shanghai (Apatinib, Oxaliplatin, 5-fluorouracil)

Enrolling by invitation
  • Apatinib
  • Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Sep 19, 2021

Colorectal Cancer Trial in Japan (oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab, oxaliplatin (OXA),

Active, not recruiting
  • Colorectal Cancer
  • oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab
  • oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, bevacizumab
  • Ichinomiya, Aichi, Japan
  • +150 more
Nov 29, 2022

Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022

Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +

Not yet recruiting
  • Stage I Colon Cancer
  • +2 more
  • Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
  • +2 more
  • Houston, Texas
    Baylor College of Medicine
May 22, 2023

Colorectal Cancer, Immunotherapy Trial in Guangzhou (mFOLFOX6+Bevacizumab+PD-1 mAb treatment combinations)

Recruiting
  • Colorectal Cancer
  • Immunotherapy
  • mFOLFOX6+Bevacizumab+PD-1 monoclonal antibody treatment combinations
  • Guangzhou, Guangdong, China
    Sun Yatsen University
May 19, 2021

Metastatic Colorectal Cancer (CRC) Trial (TRS003, China-approved Bevacizumab, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer (CRC)
  • TRS003
  • +2 more
  • (no location specified)
May 12, 2022

Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)

Active, not recruiting
Has Results
  • Colorectal Carcinoma
  • mFOLFOX6
  • +4 more
  • (no location specified)
Oct 28, 2022

Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)

Not yet recruiting
  • Esophagus Adenocarcinoma
  • Frankfurt, Germany
    Institute of Clinical Cancer Research, University Cancer Center
Jan 26, 2023

Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)

Completed
Has Results
  • Colon Cancer
  • +3 more
  • Birmingham, Alabama
  • +94 more
Nov 10, 2022

Neoadjuvant Treatment, Rectal Cancer, Bevacizumab Trial (Bevacizumab+mFOLFOX6)

Not yet recruiting
  • Neoadjuvant Treatment
  • +3 more
  • (no location specified)
Oct 28, 2021

Gastric Cancer Stage IV, Peritoneal Carcinomatosis, Intraperitoneal Paclitaxel Trial in Seongnam-si (Paclitaxel, mFOLFOX6

Recruiting
  • Gastric Cancer Stage IV
  • +3 more
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Mar 7, 2021

Neuropathy, Painful, Chemo-induced Peripheral Neuropathy, Colorectal Cancer Trial in Saint Louis (Lidocaine Hydrochloride,

Completed
Has Results
  • Neuropathy, Painful
  • +2 more
  • Lidocaine Hydrochloride
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine/Barnes Jewish Hospital
Feb 10, 2022

Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • mFOLFOX6
  • +3 more
  • Duarte, California
  • +6 more
Jan 18, 2023

Metastatic Colorectal Cancer Trial in Eschweiler, Wilhelmshaven (Maintenance Chemotherapy, Panitumumab (Within maintenance

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Maintenance Chemotherapy
  • +3 more
  • Eschweiler, Germany
  • +1 more
Sep 9, 2021

Colorectal Cancer, Neoadjuvant Chemo, Stent Trial in Beijing (Immunotherapy (Camrelizumab))

Recruiting
  • Colorectal Cancer
  • +4 more
  • Immunotherapy (Camrelizumab)
  • Beijing, Beijing, China
    Beijing Chaoyang Hospital, Capital Medical University
Jan 10, 2022

Rectal Cancer Trial in Spain (Panitumumab, 5Fluorouracil, Oxaliplatin)

Completed
  • Rectal Cancer
  • Elche, Alicante, Spain
  • +10 more
Mar 16, 2022

Rectal Cancer Trial in Wuhan (Vitamin C)

Recruiting
  • Rectal Cancer
  • Vitamin C
  • Wuhan, Hubei, China
    Zhongnan Hopital of Wuhan University
Mar 15, 2021

Solid Tumor, Adult Trial in Korea, Republic of, United States (TTX-030, budigalimab and mFOLFOX6, TTX-030, budigalimab and

Active, not recruiting
  • Solid Tumor, Adult
  • TTX-030, budigalimab and mFOLFOX6
  • +7 more
  • Scottsdale, Arizona
  • +31 more
Oct 18, 2022